DS
ONC

DRW Securities’s BeOne Medicines Ltd ONC Stock Holding History

DRW Securities’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,653
Closed -$906K – 1801
2025
Q3 		$906K Buy
+2,653
New +$806K 0.02% 411
2024
Q4 		– Sell
-2,553
Closed -$573K – 817
2024
Q3 		$573K Buy
+2,553
New +$459K 0.02% 352

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

DRW Securities's ONC Position: Q4 2025 in Review

DRW Securities sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 2,653 shares — an estimated $906K sold.

DRW Securities first reported a position in ONC in Q3 2024 and held it in 2 quarters. The position peaked at $906K in Q3 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • DRW Securities reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 2,653 BeOne Medicines Ltd shares in Q4 2025, an estimated $906K.
  • DRW Securities first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 2 quarters.
  • DRW Securities's BeOne Medicines Ltd position peaked at $906K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.